Zivo Bioscience, Inc. SEC filings ZIVO
Zivo Bioscience, Inc. has 757 filings in SEC EDGAR's recent list, going back to Apr 20, 2000. Its latest annual report, Form ARS, was filed on Apr 25, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Mar 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | S-8 | Mar 31, 2026 | — |
| POS AM | Filing | Mar 31, 2026 | — |
| S-1/A | Amended registration statement | Nov 3, 2023 | — |
| S-1/A | Amended registration statement | Nov 1, 2023 | — |
| S-1 | Registration statement | Oct 4, 2023 | — |
| 424B3 | Prospectus | Aug 3, 2023 | — |
| S-3 | Shelf registration | Jul 28, 2023 | — |
| 424B5 | Prospectus supplement | Jul 5, 2023 | — |
| S-1 | Registration statement | Mar 22, 2023 | — |
| S-8 | Employee stock plan registration | Jun 22, 2022 | — |
| S-3 | Shelf registration | Aug 26, 2021 | — |
| 424B4 | Prospectus | Jun 1, 2021 | — |
| S-1MEF | Form s-1mef | May 27, 2021 | — |
| S-1/A | Amended registration statement | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 19, 2021 | — |
| S-1/A | Amended registration statement | Apr 13, 2021 | — |
| S-1 | Registration statement | Dec 9, 2020 | — |
| S-8 | Employee stock plan registration | Feb 12, 2004 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZIVO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bloomfield Hills, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1101026
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (until Oct 16, 2014); WESTERN GLORY HOLE INC (until Jan 26, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.